Speaker Profile
CEO, OneFul Health Inc
Biography
Edison Hudson is a recognized pioneer in robotics and intelligent process automation. At Panacea BioMatx Inc, he has led the design of disruptive robotic platforms for personalized medicine and clinical nutrition driven by digital health data. He has been a key innovator in several technology companies, including iRobot, Adept Technology, Unimation, Redzone Robotics, and Meta Machines, and spent over a decade working in Silicon Valley automating semiconductor and electronics manufacturing processes. Founder of 4 companies, he holds over 25 patents in automation, machine intelligence, and automated pharmacy. A Morehead Scholar at the University of North Carolina, he studied artificial intelligence at Oxford University UK, and received an MBA from Duke University.
Wellness & Aging Showcase:
OneFul Health Inc
OneFul seeks to improve the quality of life for millions of patients with affordable personalized medicine that are easier to take. Science-based formulations, made with robotic accuracy, deliver multiple drugs combined for One Person, as prescribed by One Doctor from our accredited OneFul Pharmacies.
Personalized Cardiovascular Therapies - Genomics Meets Robotics
Fixed combination cardiovascular poly-pills have been shown to greatly improve adherence in multiple clinical studies. OneFul shows how pharmacogenomic-based formulation driving highly accurate robotics can make personalized CVD poly-therapies that are more efficacious with fewer adverse effects, further enhancing poly pharmacy adherence.
Session Abstract – PMWC 2022 Silicon Valley
The PMWC 2022 Emerging Therapeutics Showcase will provide a 15-minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
